Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025)
Arcellx (ACLX) recorded quarterly Amortizatization of Intangibles of $1.2 million in Q4 2025, down 81.77% quarter-over-quarter from $6.8 million in Q3 2025, and down 65.13% on a YoY basis from $3.6 million in Q4 2024.
Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
Arcellx's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- In Q4 2025, Amortizatization of Intangibles fell 65.13% year-over-year to $1.2 million; the TTM figure through Dec 2025 stood at $8.4 million (down 45.38% YoY), while the FY2025 annual figure was $8.4 million, down 45.38% from the prior year.
- Amortizatization of Intangibles was $1.2 million for Q4 2025 at Arcellx, down from $6.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $6.8 million in Q3 2025 to a low of -$1.4 million in Q2 2023.
- Historically, Amortizatization of Intangibles has averaged $2.1 million across 5 years, with a median of $1.2 million in 2025.
- Biggest YoY gain for Amortizatization of Intangibles was 1898.18% in 2023; the steepest drop was 2056.94% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$150000.0 in 2021, then slumped by 90.0% to -$285000.0 in 2022, then jumped by 1483.86% to $3.9 million in 2023, then retreated by 9.53% to $3.6 million in 2024, then slumped by 65.13% to $1.2 million in 2025.
- The last three Amortizatization of Intangibles figures came in at $1.2 million (Q4 2025), $6.8 million (Q3 2025), and $188000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Sep 30, 2025 | 6.83 Mn |
| Jun 30, 2025 | 188,000.00 |
| Jun 30, 2025 | 188,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Mar 31, 2025 | 186,000.00 |
| Dec 31, 2024 | 3.57 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Jun 30, 2024 | 5.58 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Mar 31, 2024 | 2.90 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Sep 30, 2023 | 6.54 Mn |
| Sep 30, 2023 | 6.54 Mn |